Dr. Jessica Ailani talks with Dr. Willebrordus Petrus Johannes Van Oosterhout about the occurrence, characteristics, and evolution of space headaches during long-duration flights. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
The April 2024 replay of past episodes showcases four incredible interviews on functional neurologic disorders. The episode begins with the 3-part FND roundtable discussion with Prof Jon Stone discussing various topics in FND with Drs. Selma Aybek, David Perez, and Sarah Lidstone. In the first discussion they touch on FND diagnosis and exploring new phenotypes. The second discussion is on how and why FND and the third discussion is on treatments for FND. The episode concludes with Dr. Halley Alexander’s conversation with Dr. Genna Waldman about reviewing psychogenic non-epileptic events. Related Links: __ __ Disclosures can be found at Neurology.org /Neurology.org.
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Jeff Ratliff speaks with Dr. Avindra Nath, the recipient of the 2024 American Brain Foundation Ted Burns Humanism in Neurology Award. Read more about the Ted Burns Humanism in Neurology Award. Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Valérie van Hezik-Wester about whether people living with severe medically refractory epilepsy (PSRE) benefit from a seizure dog. Read the related article in . Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Genevieve Rayner and Eliza Honybun about the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes. Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Carles Gaig about developing a composite score to assess the severity of the multiple symptoms present in anti-IgLON5 disease. Read the related article in . Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Aaron Baldwin about how access to genetic testing may vary based on various factors such as race, ethnicity, sex, socioeconomic status, and insurance status. Read the related article in . Disclosures can be found at Neurology.org.
Dr. Deanna Saylor talks with Drs. Gretchen Birbeck and Melody Asukile about ways to improve global collaboration among neurologists. Read the related article in JAMA Neurology. Disclosures can be found at Neurology.org.
Dr. Howard Goodkin talks with Dr. Fred Lado about the National Association of Epilepsy Centers (NAEC) updated guidelines for specialized epilepsy centers. Read the related article in . Disclosures can be found at Neurology.org.
The March 2024 recall includes three episodes taken from the 2023 November Headache Series. In part two of this two-part recall, Dr. Tesha Monteith begins with a discussion with Dr. Messoud Ashina on the mechanisms of migraine. The episode continues with Dr. Peter Goadsby talking about updates on migraine treatments and CGRP inhibitors. Finally, the episode concludes with an interview with Dr. Stewart Tepper discussing rapid developments in neuromodulation. Related Podcast Links: https://directory.libsyn.com/episode/index/id/28721028 https://directory.libsyn.com/episode/index/id/28812568 https://directory.libsyn.com/episode/index/id/28868248 Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Dr. Robert Evan Shapiro about the impact that migraine has on quality of life and the frequency of migraine-related stigma. Read the related article in . Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Jason Crowell talks with Dr. Subhojit Roy about a platform for investigating the role of serine-129 in synucleinopathies, with implications for drug development. Read the related article in the . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Gregg Day talks with Drs. Thomas J. Montine and Brenna Cholerton about whether the association between neuropathologic burden and dementia in these older groups differs substantially from those seen in younger-old adults. Read the related article in . Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. David T. Plante about the Wisconsin Sleep Cohort study to estimate the prevalence of idiopathic hypersomnia. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Justin Abbatemarco talks with Prof. Xavier Ayrignac about the importance of considering alternative diagnoses for CTLA4 deficiencies. Read the related article in .
Dr. Stacey Clardy talks with Bob Herman about a class action lawsuit that was filed against UnitedHealth Group and its subsidiary, NaviHealth, for using a computer algorithm to "systematically deny claims” of Medicare beneficiaries struggling to recover from debilitating illnesses in nursing homes. Read the related article in . Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Jason Margolesky about the frequency of blepharoclonus in Parkinson disease and atypical Parkinsonian disorders to explore whether this clinical phenomenology may be useful in the evaluation and diagnosis of patients with Parkinsonism. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org /Neurology.org.
The February 2024 recall includes three episodes taken from the 2023 November Headache Series and will be part 1 of a two-part Recall series. In the first part of this two-part recall, Dr. Tesha Monteith begins with a discussion on the highlights of the 2023 International Headache Conference with Drs. Hayrunnisa Bolay, KC Brennan, and Gianluca Coppola. The episode continues with Dr. Stephanie Nahas discussing commonly missed and lesser-known primary headache disorders. Finally, the episode concludes with an interview with Drs. Deb Friedman and Kathleen Digre, who talk about the diagnosis and management of IIH and other CSF pressure disorders. Related Podcast Links: https://directory.libsyn.com/episode/index/id/28479644 https://directory.libsyn.com/episode/index/id/28567413 https://directory.libsyn.com/episode/index/id/28675078 Disclosures can be found at Neurology.org /Neurology.org
Dr. Shuvro Roy talks with Dr. Monica T. Ly about brain lesions in former football players linked to vascular brain changes. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Tesha Monteith talks with Dr. Cecilia Hvitfeldt Fuglsang about the effects of migraine and PIH on the risk of stroke and myocardial infarction. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Deanna Saylor talks with Prof. Mayowa Owolabi about reducing the global burden of stroke. Read the related article in .
Dr. Halley Alexander talks with Dr. Genna Waldman about her presentation at the AES (Annual Epilepsy Society) symposium session reviewing PNEE (psychogenic non-epileptic events) and indications of discontinuation of medications. ARTICLES REFERENCED IN THE EPISODE: https://doi.org/10.1111/epi.12356 https://www.sciencedirect.com/science/article/pii/S1059131119300342 https://onlinelibrary.wiley.com/doi/epdf/10.1002/brb3.2567 https://doi.org/10.1111/j.1528-1167.2010.02696.x https://doi.org/10.1016/j.yebeh.2021.108004 Disclosures can be found at Neurology.org /Neurology.org.
Dr. Stacey Clardy talks with Dr. Geoff Ling about his thoughts on rapid-fire mortar shooting and more broadly, how he goes about identifying what veterans have been exposed to and treating veterans in the clinic. They also discussed a little bit about a recently published article in the New York Times titled, "A Secret War, Strange New Wounds, and Silence from the Pentagon." Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Prof. Mike Lunn about the relationship between COVID-19 vaccinations and Guillain-Barré syndrome using the National Immunoglobulin Database. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Derek Stitt talks with Dr. Ali A. Habib about trends in hospital admissions and in-hospital mortality for adult patients with MG. Read the related article in . Disclosures can be found at Neurology.org /Neurology.org.
Dr. Jason Crowell talks with Dr. Benjamin N. Rome about ways to improve pharmacy benefit managers and the way they function in the system. Read the related article in . REFERENCED IN THIS EPISODE: June 2021 Neurology Recall Episode https://directory.libsyn.com/episode/index/id/19282754 Disclosures can be found at Neurology.org /Neurology.org.
Dr. Gordon Smith talks with Dr. Haya Bishara about the association between GBS and both SARS-CoV-2 infection and the COVID-19 vaccine. Read the related article in . Disclosures can be found at Neurology.org.
The January 2024 replay starts the new year off with four previously posted episodes on dementia. The episode begins with an interview with Dr. Kenneth Langa on the prevalence of dementia and mild cognitive impairment in the US. The episode continues with an interview with Dr. Beau Ances about the burden amyloid has on individuals with Down syndrome compared to autosomal dominant Alzheimer disease. The next interview is with Dr. Erik Musiek on the use of lecanemab in early Alzheimer disease. The fourth and final interview is with Dr. Vijay Ramanan on the eligibility for anti-amyloid treatment. RELATED PODCAST LINKS: Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the United States: https://directory.libsyn.com/episode/index/id/25811241 Comparison of Amyloid Burden in Individuals with Down Syndrome Versus Autosomal Dominant Alzheimer Disease: https://directory.libsyn.com/episode/index/id/25881414 Lecanemab in Early Alzheimer Disease: https://directory.libsyn.com/episode/index/id/25428333 Eligibility for Anti-Amyloid Treatment: https://directory.libsyn.com/episode/index/id/28300052 RELATED ARTICLE LINKS: Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: https://jamanetwork.com/journals/jamaneurology/article-abstract/2797274?resultClick=1 Comparison of Amyloid Burden in Individuals with Down Syndrome Versus Autosomal Dominant Alzheimer's Disease: A Cross-Sectional Study: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00408-2/fulltext Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging: https://www.neurology.org/doi/10.1212/WNL.0000000000207770 Disclosures can be found at Neurology.org